Chemotherapy with gemcitabine, paclitaxel, and cisplatin in the treatment of patients with infiltrative transitional cell carcinoma of the urothelium

被引：0
|
作者：
Ecke, T. K.
Bartel, P.
Theissig, F.
Koch, S.
Ruttloff, J.
机构：
[1] HELIOS Klin, Dept Urol, Bad Saarow Pieskow, Germany
[2] HELIOS Klin, Inst Pathol, Bad Saarow Pieskow, Germany
来源：
EUROPEAN UROLOGY SUPPLEMENTS | 2007年 / 6卷 / 02期
关键词：
D O I：
10.1016/S1569-9056(07)60786-6
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：220 / 220
页数：1
相关论文
共 50 条
  • [1] Chemotherapy with gemcitabine, paclitaxel, and cisplatin in the treatment of patients with advanced transitional cell carcinoma of the urothelium
    Ecke, Thorsten H.
    Bartel, Peter
    Koch, Stefan
    Ruttloff, Juergen
    Theissig, Franz
    [J]. ONCOLOGY REPORTS, 2006, 16 (06) : 1381 - 1388
  • [2] Gemcitabine and paclitaxel combination therapy in transitional cell carcinoma of the urothelium
    Meluch, A. A.
    Burris, H. S.
    Greco, F. A.
    Hainsworth, J. D.
    [J]. EUROPEAN JOURNAL OF CANCER, 2000, 36 : S30 - S33
  • [3] Final Results of Sequential Doxorubicin Plus Gemcitabine and Ifosfamide, Paclitaxel, and Cisplatin Chemotherapy in Patients With Metastatic or Locally Advanced Transitional Cell Carcinoma of the Urothelium
    Milowsky, Matthew I.
    Nanus, David M.
    Maluf, Fernando C.
    Mironov, Svetlana
    Shi, Weiji
    Iasonos, Alexia
    Riches, Jamie
    Regazzi, Ashley
    Bajorin, Dean F.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (25) : 4062 - 4067
  • [4] Phase I trial of paclitaxel, cisplatin, and gemcitabine (TCG) in patients (p) with advanced transitional cell carcinoma (TCC) of the urothelium
    Bellmunt, J
    Baselga, J
    [J]. SEMINARS IN ONCOLOGY, 1999, 26 (01) : 140 - 140
  • [5] Gemcitabine in the treatment of advanced transitional cell carcinoma of the urothelium
    Bellmunt, J.
    Albiol, S.
    Ramirez de Olano, A.
    Pujadas, J.
    Maroto, P.
    [J]. ANNALS OF ONCOLOGY, 2006, 17 : V113 - V117
  • [6] Gemcitabine and carboplatin in the treatment of transitional cell carcinoma of the urothelium
    Hudson, E.
    Lester, J. F.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [7] Re: Final results of sequential doxorubicin plus gemcitabine and ifosfamide, paclitaxel, and cisplatin chemotherapy in patients with metastatic or locally advanced transitional cell carcinoma of the urothelium
    Logothetis, Christopher J.
    Siefker-Radtke, Arlene
    [J]. EUROPEAN UROLOGY, 2010, 57 (04) : 728 - 729
  • [8] Chemotherapy for advanced transitional cell carcinoma of the urothelium: Cisplatin or carboplatin?
    Culine, Stephane
    [J]. EUROPEAN UROLOGY, 2007, 52 (01) : 9 - 10
  • [9] Randomised, open-label, phase II trial of paclitaxel, gemcitabine and cisplatin versus gemcitabine and cisplatin as first-line chemotherapy in advanced transitional cell carcinoma of the urothelium
    Lorusso, V
    Crucitta, E
    Silvestris, N
    Rosati, G
    Manzione, L
    De Lena, M
    [J]. ONCOLOGY REPORTS, 2005, 13 (02) : 283 - 287
  • [10] Phase I-II study of paclitaxel, cisplatin, and gemcitabine in advanced transitional-cell carcinoma of the urothelium
    Bellmunt, J
    Guillem, V
    Paz-Ares, L
    González-Larriba, JL
    Carles, J
    Batiste-Alentorn, E
    Sáenz, A
    López-Brea, M
    Font, A
    Nogué, M
    Bastús, R
    Climent, MA
    de la Cruz, JJ
    Albanell, J
    Banús, JM
    Gallardo, E
    Diaz-Rubio, E
    Cortés-Funes, H
    Baselga, J
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (18) : 3247 - 3255
12345